SRS Capital Advisors »

Prelude Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $40 19 2.11
2024-06-30 $72 19 3.84

More positions owned by SRS Capital Advisors

Vanguard Index Fds Value Etf (VTV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Schwab Strategic Tr Us Tips Etf (SCHP)
Vanguard Index Fds Growth Etf (VUG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Vanguard Index Fds Mid Cap Etf (VO)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for SRS Capital Advisors

Top funds holding Prelude Therapeutics

OrbiMed Advisors
Baker Bros. Advisors
Deerfield Management Company
Boxer Capital
T. Rowe Price Associates
BlackRock
BlackRock
Vanguard Group
ExodusPoint Capital Management
Avidity Partners Management
Massachusetts Financial Services
Geode Capital Management
Marshall Wace
Sio Capital Management
Morgan Stanley

View all funds holding Prelude Therapeutics